The Intercept @theintercept
Monoclonal antibodies are already among the most expensive pharmaceutical products available. The treatments on the market for conditions other than Covid-19 cost an average of $96,731 per year. https://t.co/Z6Lrr1JKDG — PolitiTweet.org